Pradžia › Glioma › Ohio › Columbus

Glioma klinikiniai tyrimai Columbus, OH

15 tyrimai dėl Glioma ieško dalyvių vietose Columbus ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Renkami dalyviai1/2 fazė

Nationwide Children's Hospital, Columbus

12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-10-01 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Renkami dalyviai2 fazė

Ohio State University, Columbus

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Renkami dalyviai2 fazė

Nationwide Children's Hospital, Columbus

12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-09-21 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Renkami dalyviaiStebimasis tyrimas

Nationwide Children's Hospital, Columbus

12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-09-08 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Renkami dalyviai2 fazė

Nationwide Children's Hospital, Columbus

Amžius nuo 12 iki 39 · Visoms lytims · Atnaujinta 2026-09-01 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Renkami dalyviai2 fazė

Nationwide Children's Hospital, Columbus

Amžius nuo 3 iki 39 · Visoms lytims · Atnaujinta 2026-08-24 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Renkami dalyviai2 fazė

The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus

Amžius 8 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT05503797

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Renkami dalyviai

Ohio State University Medical Center, Columbus

Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-07-21 · NCT06910306

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Renkami dalyviai1/2 fazė

Nationwide Children's Hospital, Columbus

Amžius nuo 4 iki 39 · Visoms lytims · Atnaujinta 2026-07-20 · NCT05278208

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Renkami dalyviaiAnkstyvoji 1 fazėLaukiami sveiki savanoriai

Nationwide Children's Hospital, Columbus

Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2026-06-29 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Renkami dalyviai2 fazė

Nationwide Children's Hospital, Columbus

12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-05-29 · NCT05843253

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

Renkami dalyviai1 fazė

Ohio State University Comprehensive Cancer Center, Columbus

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-08 · NCT06964737

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Renkami dalyviai1/2 fazė

Ohio State University Comprehensive Cancer Center, Columbus

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-13 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Renkami dalyviaiAnkstyvoji 1 fazė

Nationwide Children's Hospital, Columbus

Iki 21 metų · Visoms lytims · Atnaujinta 2026-03-18 · NCT04655404

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

Renkami dalyviai1 fazė

Nationwide Children's Hospital, Columbus

12 Months – 39 Years · Visoms lytims · Atnaujinta 2025-05-13 · NCT04254419

Glioma tyrimai kituose miestuose

Kiti tyrimai Columbus

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.